David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$410M |
| 2 |
Chevron
CVX
|
+$400M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$381M |
| 4 |
Williams Companies
WMB
|
+$300M |
| 5 |
SLB Ltd
SLB
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$358M |
| 3 |
Biogen
BIIB
|
+$306M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$298M |
| 5 |
Bausch Health
BHC
|
+$298M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 11.89% |
| 2 | Technology | 10.04% |
| 3 | Healthcare | 9.38% |
| 4 | Consumer Discretionary | 8.99% |
| 5 | Industrials | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Lennar Class A
LEN
$21.2B
| $23.3M | 0.03% |
478,785
-552,233
| -54% | -$25.4M |
|
|
ALR
577
DELISTED
Alere Inc
ALR
| $23.2M | 0.03% |
440,741
+54,139
| +14% | +$2.72M |
|
578
CALL
Verizon
VZ
$208B
| $23.2M | 0.03% |
497,600
-143,800
| -22% | -$7.04M |
|
579
Ventas
VTR
$47.9B
| $23.2M | 0.03% |
326,959
+322,653
| +7,493% | +$25.2M |
|
580
NXP Semiconductors
NXPI
$56.1B
| $23.1M | 0.03% |
235,364
-533,370
| -69% | -$54.7M |
|
|
FOLD
581
DELISTED
Amicus Therapeutics
FOLD
| $23.1M | 0.03% |
1,630,724
-938,602
| -37% | -$11.3M |
|
582
Opko Health
OPK
$1.1B
| $23M | 0.03% |
1,432,857
+1,413,655
| +7,362% | +$22M |
|
|
TMX
583
DELISTED
Terminix Global Holdings, Inc.
TMX
| $23M | 0.03% |
949,560
+856,524
| +921% | +$19.9M |
|
|
HRC
584
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $23M | 0.03% |
423,194
+100,163
| +31% | +$5.2M |
|
|
MR
585
DELISTED
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR
| $23M | 0.03% |
805,722
+60,312
| +8% | +$1.76M |
|
586
Lear
LEA
$8.18B
| $22.8M | 0.03% |
203,318
-121,025
| -37% | -$13.9M |
|
587
PUT
Viatris
VTRS
$19B
| $22.6M | 0.03% |
333,700
+164,400
| +97% | +$11.6M |
|
588
PUT
Berkshire Hathaway Class B
BRK.B
$1.08T
| $22.6M | 0.03% |
166,000
-30,000
| -15% | -$4.28M |
|
589
Quest Diagnostics
DGX
$26.9B
| $22.4M | 0.03% |
309,366
+150,912
| +95% | +$11.1M |
|
590
Teleflex
TFX
$5.86B
| $22.4M | 0.03% |
165,496
-16,917
| -9% | -$2.15M |
|
|
LNKD
591
PUT
DELISTED
LinkedIn Corporation
LNKD
| $22.4M | 0.03% |
108,200
-10,100
| -9% | -$2.25M |
|
592
McKesson
MCK
$102B
| $22.3M | 0.03% |
99,095
+36,127
| +57% | +$8.35M |
|
593
Wells Fargo
WFC
$256B
| $22.2M | 0.03% |
394,890
-2,137,120
| -84% | -$119M |
|
594
ConocoPhillips
COP
$160B
| $22.1M | 0.03% |
360,602
+216,371
| +150% | +$14.1M |
|
595
Autohome
ATHM
$2.52B
| $22M | 0.03% |
434,905
+402,005
| +1,222% | +$19.8M |
|
596
Leidos
LDOS
$17.4B
| $21.9M | 0.03% |
543,485
-227,649
| -30% | -$9.57M |
|
|
RTN
597
PUT
DELISTED
Raytheon Company
RTN
| $21.9M | 0.03% |
229,200
| – | – |
|
598
CALL
FedEx
FDX
$79.1B
| $21.9M | 0.03% |
128,400
+6,500
| +5% | +$1.13M |
|
599
PUT
Las Vegas Sands
LVS
$30.4B
| $21.6M | 0.03% |
411,400
+84,100
| +26% | +$4.49M |
|
600
Sherwin-Williams
SHW
$84.2B
| $21.6M | 0.03% |
235,608
+37,500
| +19% | +$3.55M |
|
Similar funds
David Shaw's Q2 2015 Portfolio in Review
As of Q2 2015, David Shaw held 4,083 positions worth $67.1B, up 2.8% from $65.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw's Q2 2015 filing shows 504 new, 1,541 increased, 1,229 reduced and 364 closed positions. Its largest new stake was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $479M.
By sector, the portfolio is most concentrated in Energy at 12% of assets, up from 10% a quarter earlier, followed by Technology and Healthcare.
- David Shaw's largest Q2 2015 buy was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M.
- David Shaw added most to Gilead Sciences in Q2 2015, an estimated $410M increase.
- David Shaw's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $479M.
- David Shaw fully exited TRW AUTOMOTIVE HOLDINGS CORP in Q2 2015, selling an estimated $164M.
- David Shaw's ten largest holdings make up 11% of its $67.1B portfolio in Q2 2015.
- David Shaw opened 504 new positions and closed 364 in Q2 2015.
- David Shaw's portfolio value rose 2.8% quarter-over-quarter to $67.1B.
Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.